Clin2
NCT04706910Possibly a fitRecruiting

PET scan study to optimize imaging in several diseases

Congenital HyperinsulinismNeuroblastomaParkinson DiseaseLewy Body DiseaseNeuroendocrine TumorsBrain Tumor

Treatments studied

Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.

This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
800 people
Ages
Any age
Study type
Interventional

Who can take part

  • You are younger than 18 with congenital hyperinsulinism or neuroblastoma, or you are 18+ with one of the listed tumor or brain conditions
  • The diagnosis is one of these: neuroendocrine tumor (known or suspected), Parkinson’s disease, Lewy body dementia, or a brain tumor
  • You can give consent (or a parent/guardian can) for the scan study
  • You can stay in the scanner and lie flat for about 20–30 minutes during the PET-CT
  • You have no pregnancy and can safely receive an IV medicine (you have IV access)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07195500Recruiting
Imaging scans for neuroblastoma and related tumors

This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.

Nanjing, Jiangsu
NCT04205604Recruiting· Phase 2
FDOPA PET scan to locate excess insulin in infancy

This Phase 2 study uses an FDOPA PET scan to find where insulin overproduction is coming from in focal congenital hyperinsulinism (FoHI) or related conditions. The goal is to help doctors better detect and localize the “source” so treatment can be more targeted.

San Francisco, California
NCT06852807Recruiting
New PET scan for neuroblastoma in children

This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.

Hangzhou, Zhejiang
NCT07111117Not yet recruiting· Phase 2
Comparing two scans to find neuroblastoma in children

This study compares two types of imaging scans to see which is better at finding neuroblastoma in children. Your child will get both a standard MIBG scan and a newer PET scan, and the results will be compared to help improve future detection.

Paris
NCT07542158Enrolling by invitation· Phase 2
Ultra-Low Radiation PET Imaging Study for Brain Scanning

This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.

Englewood, New Jersey
NCT06667726Recruiting· Phase 2
New PET scan for better brain tumor care

This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.

Rochester, Minnesota

Hear when a new Congenital Hyperinsulinism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.